End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 CNY | +1.23% | +6.67% | -4.93% |
Business Summary
Number of employees: 4,367
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Production - Cardiovascular System
29.4
%
| - | - | 798 | 29.4 % | - |
Pharmaceutical Production - Pediatrics
22.4
%
| - | - | 610 | 22.4 % | - |
Pharmaceutical Wholesale
15.7
%
| 313 | 11.3 % | 427 | 15.7 % | +36.37% |
Pharmaceutical Production - Pain Relief
7.3
%
| - | - | 197 | 7.3 % | - |
Pharmaceutical Production - Other
5.7
%
| 53 | 1.9 % | 156 | 5.7 % | +191.51% |
Pharmaceutical Production - Psychiatry and Neurology
5.5
%
| - | - | 150 | 5.5 % | - |
Pharmaceutical Production - Raw Materials
4.2
%
| 114 | 4.1 % | 114 | 4.2 % | -0.06% |
Pharmaceutical Production - Digestive System
2.9
%
| - | - | 79 | 2.9 % | - |
Pharmaceutical Production - Heat Clearing Detoxification
2.6
%
| - | - | 70 | 2.6 % | - |
Other Business
1.4
%
| - | - | 37 | 1.4 % | - |
Pharmaceutical Production - Anti-infection
1.3
%
| - | - | 35 | 1.3 % | - |
Other Trade
1.3
%
| 30 | 1.1 % | 34 | 1.3 % | +14.03% |
Pharmaceutical Production - Gynecology
0.4
%
| - | - | 11 | 0.4 % | - |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 2,764 | 100.0 % | 2,718 | 100.0 % | -1.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 40 | 19-04-22 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 52 | - |
Wu Xian Ren
CHM | Chairman | 64 | - |
Peng Bo Ren
BRD | Director/Board Member | 51 | 07-03-10 |
Ying Kang Yang
IRC | Investor Relations Contact | - | - |
Yu Hong Yu
PRN | Corporate Officer/Principal | 52 | 11-06-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wu Xian Ren
CHM | Chairman | 64 | - |
Zhen Jiang Xu
CHM | Chairman | 51 | 14-05-14 |
Peng Bo Ren
BRD | Director/Board Member | 51 | 07-03-10 |
Wei Ren
CEO | Chief Executive Officer | 40 | 19-04-22 |
Bin Wu
BRD | Director/Board Member | 64 | 23-05-17 |
Hui Qiang Ning
BRD | Director/Board Member | 54 | 20-06-15 |
Gang Wang
BRD | Director/Board Member | 50 | 20-06-15 |
Junyan Liu
BRD | Director/Board Member | 58 | 20-06-15 |
Chun jiang Yu
BRD | Director/Board Member | 54 | 20-06-15 |
Yong Tan
BRD | Director/Board Member | 46 | 20-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 720,000,094 | 602,443,717 ( 83.67 %) | 0 | 83.67 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
10,000,000 | 1.30% | 8,592,200 $ |
Company contact information
Yabao Pharmaceutical Group Co., Ltd.
11/F, Building 2, Yard 11 Tianhua North Street
100176, Beijing
+86 35 9338 8114
http://www.yabao.com.cnSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.93% | 640M | |
+21.40% | 43.18B | |
+20.67% | 22.59B | |
+17.15% | 14.56B | |
+40.40% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
- Company Yabao Pharmaceutical Group Co., Ltd